Impact of direct mesenteric perfusion on malperfusion in acute type A aortic dissection repair
European Journal of Cardio-Thoracic Surgery · 2024
DOI: 10.1093/ejcts/ezae452 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2024. Verfasst von Ryota Yamamoto und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Aortic Dissection, Mesenteric Ischemia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
OBJECTIVES Mesenteric malperfusion in acute aortic dissection remains a life-threatening complication with no standardized treatment strategy. This study aimed to describe and evaluate the outcomes of our integrated approach combining exploratory laparotomy, immediate mesenteric reperfusion, and central aortic repair. METHODS We retrospectively reviewed patients with acute aortic dissection with a preoperative diagnosis of mesenteric malperfusion who were treated between August 2011 and November 2022. Our surgical approach was to establish cardiopulmonary bypass, followed by exploratory laparotomy with mesenteric artery flow assessment using Doppler ultrasound and direct perfusion if needed, central aortic repair, and subsequent mesenteric artery reconstruction. The primary end-point was the 30-day operative mortality. RESULTS Among 217 patients with acute aortic dissection, 12 (5.5%) had mesenteric malperfusion on preoperative computed tomography. Ten patients underwent exploratory laparotomy, where Doppler ultrasonography revealed reduced mesenteric blood flow in five patients (2.3% of the total 217 patients). These patients underwent direct perfusion of the mesenteric artery via a side branch of the cardiopulmonary bypass circuit. Doppler ultrasound confirmed the restoration of mesenteric blood flow in all perfused patients. No bowel resections were required. The operative mortality in patients with mesenteric malperfusion was 20%. The causes of death were stroke (n = 1) and acute myocardial infarction (n = 1). CONCLUSIONS Our integrated surgical strategy combining central aortic repair with concurrent exploratory laparotomy and immediate mesenteric perfusion demonstrated technical feasibility in managing mesenteric malperfusion during aortic repair. Further prospective studies with larger cohorts are warranted to validate these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Cardiovascular Surgery, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.
ORCID-Profile: Ryota Yamamoto, Wataru Kato, Yoshiyuki Tokuda, Tomonari Uemura, Hideki Ito, Tomo Yoshizumi, Sachie Terazawa, Yuji Narita, Masato Mutsuga
Zitieren
APA
Yamamoto, R., Kato, W., Tokuda, Y., Yamaki, K., Morita, K., Uemura, T., Yamamoto, T., Ito, H., Yoshizumi, T., Terazawa, S., Narita, Y., & Mutsuga, M. (2024). Impact of direct mesenteric perfusion on malperfusion in acute type A aortic dissection repair. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezae452
Vancouver
Yamamoto R, Kato W, Tokuda Y, Yamaki K, Morita K, Uemura T, et al. Impact of direct mesenteric perfusion on malperfusion in acute type A aortic dissection repair. European Journal of Cardio-Thoracic Surgery. 2024. doi:10.1093/ejcts/ezae452
BibTeX
@article{Yamamoto2024,
author = {Yamamoto, Ryota and Kato, Wataru and Tokuda, Yoshiyuki and Yamaki, Koshi and Morita, Koji and Uemura, Tomonari and Yamamoto, Toshikuni and Ito, Hideki and Yoshizumi, Tomo and Terazawa, Sachie and Narita, Yuji and Mutsuga, Masato},
title = {Impact of direct mesenteric perfusion on malperfusion in acute type A aortic dissection repair},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2024},
doi = {10.1093/ejcts/ezae452}
}
EUVIMED